Sanomedics, Inc.: 10-Q filed 2013-08-20
What Sanomedics, Inc. reported in its quarterly report filed 2013-08-20 (fiscal Q2 2013): 27 published measures, 72 facts as tagged in accession 0001477932-13-003954.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2013-08-20
- Fiscal period
- fiscal Q2 2013
- Accession
- 0001477932-13-003954 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Sanomedics, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 593,032 | USD | |
| At 2012-12-31 | 90,217 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 5,289,923 | USD | |
| At 2012-12-31 | 3,254,403 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | -4,696,891 | USD | |
| At 2012-12-31 | -3,164,186 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 72,482 | USD | |
| At 2012-12-31 | 26,084 | USD | |
| At 2012-06-30 | 2,959 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | -2,130,407 | USD | 91 |
| 2013-01-01 to 2013-06-30 | -2,569,979 | USD | 181 |
| 2012-04-01 to 2012-06-30 | -586,785 | USD | 91 |
| 2012-01-01 to 2012-06-30 | -1,036,821 | USD | 182 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-06-30 | 45 | USD | 182 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-06-30 | -45 | USD | 182 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | -11,483,261 | USD | |
| At 2012-12-31 | -8,913,282 | USD |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 15,741 | USD | |
| At 2012-12-31 | 17,049 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | 38,842 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 255,738 | USD | 181 |
| 2012-04-01 to 2012-06-30 | 204,888 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 369,751 | USD | 182 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | -289,247 | USD | 91 |
| 2013-01-01 to 2013-06-30 | -679,357 | USD | 181 |
| 2012-04-01 to 2012-06-30 | -532,296 | USD | 91 |
| 2012-01-01 to 2012-06-30 | -927,865 | USD | 182 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 534,986 | USD | |
| At 2012-12-31 | 36,372 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | 27,092 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 53,115 | USD | 181 |
| 2012-04-01 to 2012-06-30 | 54,489 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 108,956 | USD | 182 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 4,155,886 | USD | |
| At 2012-12-31 | 3,241,903 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 49,376 | USD | |
| At 2012-12-31 | 8,117 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | 336,167 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 766,844 | USD | 181 |
| 2012-04-01 to 2012-06-30 | 526,936 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 928,201 | USD | 182 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 2,318 | USD | |
| At 2012-12-31 | 2,171 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | 46,920 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 87,487 | USD | 181 |
| 2012-04-01 to 2012-06-30 | -5,360 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 336 | USD | 182 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | 25,750 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 53,500 | USD | 181 |
| 2012-01-01 to 2012-06-30 | 8,500 | USD | 182 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 20,508,609 | shares | |
| At 2012-12-31 | 20,403,586 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 6,785,860 | USD | |
| At 2012-12-31 | 5,748,691 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | -2,130,407 | USD | 91 |
| 2013-01-01 to 2013-06-30 | -2,569,979 | USD | 181 |
| 2012-04-01 to 2012-06-30 | -586,785 | USD | 91 |
| 2012-01-01 to 2012-06-30 | -1,036,821 | USD | 182 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | 269,676 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 453,808 | USD | 181 |
| 2012-04-01 to 2012-06-30 | 320,987 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 547,828 | USD | 182 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-06-30 | 3,798 | USD | 181 |
| 2012-01-01 to 2012-06-30 | 2,122 | USD | 182 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | -1,841,160 | USD | 91 |
| 2013-01-01 to 2013-06-30 | -1,890,622 | USD | 181 |
| 2012-04-01 to 2012-06-30 | -54,489 | USD | 91 |
| 2012-01-01 to 2012-06-30 | -108,956 | USD | 182 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-06-30 | -41,259 | USD | 181 |
| 2012-01-01 to 2012-06-30 | -4,600 | USD | 182 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-06-30 | -147 | USD | 181 |
| 2012-01-01 to 2012-06-30 | 29,867 | USD | 182 |
Inspect the source
- Entity
- Sanomedics, Inc. / CIK 0001501972
- Captured
- SEC response SHA-256
6c0af9720a10416680c6fc5e8d6f44722f1dfb1953be5b58d23cea65d053ff75
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001501972.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))